LDP Vials - Ompi - Stevanato Group - Stevanato Group
LDP Vials minimize risk of delamination thanks to an optimized low-heating glass vial forming process mitigating the risk of surface inhomogeneities formation. SG LDP Vials.
Home - Managing Complexity, Delivering Value - Stevanato Group > Products & Capabilities - Stevanato Group > Drug containment solutions: Pharmaceutical glass containers - Stevanato Group > Pharmaceutical glass vials: glass vials system - Stevanato Group > LDP Vials - Ompi - Stevanato Group - Stevanato Group
After conducting extensive research on the chemical performance of the glass vial inner surface and the glass forming process parameters, Stevanato Group added LDP Vials to its portfolio. These containers are specifically designed to minimize the formation of surface inhomogeneities.
LDP Vials are produced with Type 1 Borosilicate glass and have no coating, meaning that there is no need to re-file to Official Authorities.
Discovering our range of LDP Vials
Watch Video
The issue
The delamination of pharmaceutical glass is a serious issue as it can cause glass particles to appear in a vial. The first step is the formation of an altered layer that leads to the separation of thin glass flakes.
LDP lamellae test
Factors leading to delamination
Drug formulation: aggressive buffers, complexing agents, high pH
Storage Conditions: temperature, time, etc.
Surface Treatments: presence sulfur, coating, etc.
Process and shelf life: depyrogenation, terminal sterilization, etc.
Delamination may cause
Compromised drug integrity
Product recalls
Reduced product shelf life
2R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R both EZ-fill® and bulk
Benefits
Higher stability of the drug during its shelf life
No glass formulation changes
No need to re-file your drug
No coatings
Comparable to the raw material in terms of release of glass elements